Vaxcyte, Inc.
PCVX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,906 | $4,422 | $5,124 | $10,056 |
| - Cash | $281 | $307 | $347 | $388 |
| + Debt | $84 | $86 | $87 | $71 |
| Enterprise Value | $4,709 | $4,202 | $4,864 | $9,739 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$5 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$210 | -$162 | -$176 | -$53 |
| % Margin | – | – | – | – |
| Net Income | -$213 | -$167 | -$141 | -$137 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.56 | -1.22 | -1.04 | -1.12 |
| % Growth | -27.9% | -17.3% | 7.1% | – |
| Operating Cash Flow | -$143 | -$121 | -$166 | -$111 |
| Capital Expenditures | -$12 | $20 | -$27 | -$30 |
| Free Cash Flow | -$155 | -$102 | -$193 | -$141 |